NCT04021927 is a NA clinical trial of Ring Phototherapy in Jaundice, sponsored by University of Minnesota.

Who is sponsoring NCT04021927?

NCT04021927 is sponsored by University of Minnesota.

What drugs are being tested in NCT04021927?

Interventions in NCT04021927: Ring Phototherapy.

What condition does NCT04021927 study?

NCT04021927 studies Jaundice, Jaundice, Neonatal.

Is NCT04021927 still recruiting?

NCT04021927 is currently withdrawn. Last updated 23 February 2021.

Last reviewed 2021-02-23 · How we verify

NCT04021927

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy

Withdrawn NA Last updated 23 February 2021

What this trial tests

NA trial testing Ring Phototherapy in Jaundice. Withdrawn.

Timeline

1 September 2019

Primary endpoint
1 January 2021

1 January 2021

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	1 September 2019
Primary completion	1 January 2021
Estimated completion	1 January 2021
Sites	1 location across United States

Drugs / interventions tested

Ring Phototherapy

Conditions studied

Jaundice — all drugs for Jaundice →
Jaundice, Neonatal — all drugs for Jaundice, Neonatal →

Sponsor

University of Minnesota

Who can join

Under 7 Days, any sex, with Jaundice or Jaundice, Neonatal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a descriptive prospective study of safety and efficacy of the reflective PT ring device. Neonates with an elevated total serum bilirubin (TSB) meeting PT criteria per their clinician during hospital admission will be eligible for enrollment after informed parental consent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Jaundice

Currently open trials in the same condition.

NCT06421844 — A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images · recruiting
NCT06173947 — SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury · recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04021927 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 23 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04021927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing